Key facts
- Alpha Pharm’s last known valuation is $5.6M (Sep 2014).
- Notable investors include Fledge Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Alpha Pharm
- ·The full record, as it builds
Funding rounds
No funding rounds for Alpha Pharm are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Alpha Pharm
Operator of a community pharmacy network providing retail pharmaceutical and primary healthcare services intended to support patients in managing their health and wellness. The company offers a range of services, including prescription dispensing, over-the-counter medication sales, clinic services, vaccination programs, and patient support initiatives through a network of franchise pharmacies, enabling patients to access healthcare products and services in a community-based setting.
- Sector
- Healthcare
- HQ
- Pretoria, South Africa
- Website
- alphapharmacies.co.za/
- Ownership
- Privately Held (backing)
Alpha Pharm doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Alpha Pharm shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Alpha Pharm in its N-PORT filings yet. We sweep new filings monthly.